YCBD Share Price Performance
US$1.59
-1.30 (-44.94%)
20.5% undervalued intrinsic discount
US$2.00
Fair Value
Price US$1.59
AnalystConsensusTarget US$2.00
Fair ValueUS$2.00
Share Pricen/a
cbdMD, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
YCBD Community Narratives
AN
Fair Value US$2 20.5% undervalued intrinsic discount
Hemp-Derived CBD And Functional Beverages Will Drive Long-Term Market Share Gains
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Hemp-Derived CBD And Functional Beverages Will Drive Long-Term Market Share Gains
Catalysts About cbdMD cbdMD develops and markets science-focused, hemp-derived CBD and functional beverage products for humans and pets across direct-to-consumer and wholesale channels. What are the underlying business or industry changes driving this perspective?Read more
2
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$2
20.5% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
4.57% p.a.
Profit Margin
20.87%
Future PE
5.88x
Price in 2028
US$1.36
Trending Discussion
Recently Updated Narratives
AN
Hemp-Derived CBD And Functional Beverages Will Drive Long-Term Market Share Gains
Fair Value: US$2 20.5% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
cbdMD, Inc. Key Details
About YCBD
- Founded
- n/a
- Employees
- 42
- CEO
- WebsiteView website
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
